Second- and third-line therapy in gastric cancer/new options for therapy

被引：0
|
作者：
Schmalenberg, H. [1 ]
机构：
[1] Krankenhaus Dresden Friedrichstadt, Med Klin 4, Dresden, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V435
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [41] Second- or Third-line Therapy for advanced Renal Cell Carcinoma after Anti-PD1/L Failure
    Rexer, Heidrun
    Banek, Severine
    Doehn, Christian
    [J]. AKTUELLE UROLOGIE, 2022, 53 (02) : 122 - 123
  • [42] Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer in the Era of Personalized Medicine
    Biswas, Bivas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 524 - 524
  • [43] Enzalutamide effective as third-line therapy
    [J]. Nature Reviews Urology, 2014, 11 (2) : 67 - 67
  • [44] Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
    Bendell, Johanna C.
    Nemunaitis, John
    Vukelja, Sasha J.
    Hagenstad, Christopher
    Campos, Luis T.
    Hermann, Robert C.
    Sportelli, Peter
    Gardner, Lesa
    Richards, Donald A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4394 - 4400
  • [45] Cost-effectiveness analysis of nivolumab and apatinib in third-line gastric cancer therapy.
    Yuan, Jiajia
    Shen, Lin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer
    Brodowicz, T
    Koestler, WJ
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Zielinski, CC
    [J]. ANTI-CANCER DRUGS, 2000, 11 (03) : 149 - 153
  • [47] FOLFIRI regimen as second- and third-line chemotherapy for metastatic biliary tract or pancreatic cancer.
    Loioia, Fernanda Navarro
    Guedes Camandaroba, Marcos Pedro
    Oliveira Fernandes, Viviane Teodoro
    Rodrigues Pereira, Augusto Akikubo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Predictors of second- and third-line chemotherapy receipt in stage IV colon cancer Medicare beneficiaries
    Reese, Emily S.
    Onukwugha, Ebere
    Hanna, Nader
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [49] Capecitabine as Second- and Third-line Chemotherapy in the Treatment of Platinum-refractory Epithelial Ovarian Cancer
    Veljanoska, S.
    Klisarovska, V.
    Arsovski, O.
    Basevska, N.
    Stojkovski, I.
    Simonova, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S537 - S537
  • [50] New options for second-line therapy of advanced renal cancer
    Bex, Axel
    [J]. LANCET ONCOLOGY, 2013, 14 (06): : 450 - 451
12345